pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026 
Antares Pharma to Report First Quarter 2021 Financial and Operating Results
EWING, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today...
Predictive Oncology Inc. Announces Newest Board Member
MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”)...
CohBar Appoints Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and Director
Announces change to the Board of Director’s ChairMENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR),...
Allogene Therapeutics to Report First Quarter Financial Results on May 5, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) --...
Top Executive at PBS, BBC America, Viacom Productions, and NBC Entertainment Joins Clubhouse Media Advisory Board
LOS ANGELES, April 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS:CMGR) (“Clubhouse Media” or the...
Terranueva Announces Changes to Its Management Team and Board of Directors
MONTREAL, April 27, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Terranueva Corporation (CSE: TEQ) ("Terranueva" or the "Company")...
Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development
Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND...
Golden Leaf Reports Record 2020 Revenues of $21.9 Million and First Adjusted EBITDA1 Positive Quarter
Six months of positive cash flow from operations. Turnaround complete and focused on growth and optimization.PORTLAND, Ore., April 27, 2021...
NeuBase Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference
PITTSBURGH, April 27, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase”), a biotechnology company accelerating the genetic revolution...
Daré Bioscience Announces Ovaprene®, a Novel Investigational Hormone-Free Contraceptive, Poster Presentation at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data...
Wesana Health Adds Israel Mirsky as Chief Strategy Officer
CHICAGO, April 27, 2021 (GLOBE NEWSWIRE) -- Wesana Health Inc. (“Wesana” or the “Company”), an emerging life sciences company focused...
Jounce Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on Tuesday, May 4, 2021
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Equillium Announces Three Abstracts Accepted for Presentation at the 104th Annual Meeting of the American Association of Immunologists
Presentations highlight the pathogenic role of the CD6-ALCAM pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic...
Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands Scientific Advisory Team
Strengthens therapeutic development programs with key hires in Pharmacology and ToxicologyVANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- Bright...
Newly Released Data on Three PGHD Patients Treated with LUM-201 in Prior Phase 2 Study To Be Presented in Lumos Pharma Key Opinion Leader Webinar
Virtual KOL Event is scheduled for Today, April 27th @ 10:30 AM ETAUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) --...
Pyxis Oncology Presents Preclinical Data and Details on Antibody-Drug Conjugate Candidates Supporting Therapeutic Potential
Pyxis Oncology to host webcast with Key Opinion Leaders (KOLs) on April 27, 2021 at 1:00pm ETCAMBRIDGE, Mass., April 27,...
Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution
FINTEPLA is approved in the U.S. and European Union as an add-on therapy for the treatment of seizures associated with...
T2 Biosystems Announces Meta-analysis of Controlled Studies in Peer-Reviewed Medical Journal Highlighting the Benefits of T2MR Technology Compared to Blood Culture
Study concludes the utilization of T2 Magnetic Resonance (T2MR®) provides faster time to detection, faster time to targeted therapy, and...
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors
Dr. Curley brings extensive pharmaceutical industry experience in product development, commercialization and operations as VistaGen advances late-stage development of its...
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
Additional case studies support the broad potential of AC5® Advanced Wound System in chronic and non-healing woundsFRAMINGHAM, Mass., April 27,...